Literature DB >> 25244412

The 2-week wait service: a UK tertiary colorectal centre's experience in the early identification of colorectal cancer.

Rikesh K Patel1, Adele E Sayers, Shahid Seedat, Talal Altayeb, Iain A Hunter.   

Abstract

OBJECTIVES: National Institute for Health and Clinical Excellence (NICE) guidelines were introduced in the UK to ensure that patients with high-risk symptoms of colorectal cancer were reviewed promptly. We assessed the proportion of patients referred to our department's nurse-led 2-week wait (2WW) clinic with high-risk symptoms or signs that met these guidelines and the rate of colorectal cancer pickup. PATIENTS AND METHODS: Patients were identified from a prospectively maintained logbook of 2WW referrals over a 1-year period (1 January 2008-31 December 2008). Computerized notes were reviewed to obtain the following information: referral symptoms or signs and the proportion of patients diagnosed with colorectal cancer.
RESULTS: A total of 720 patients were seen in the 2WW clinic over this period. Only 356/720 (49.4%) met the referral criteria. The overall pickup rate of colorectal cancer was 52/720 (7.2%) and was not found to be significantly higher in patients meeting guidelines compared with those who did not exhibit these features (7.6 vs. 6.9%; P=0.771). Over the 5-year follow-up period, no patients discharged from the 2WW pathway subsequently re-presented with colorectal cancer.
CONCLUSION: Over half of the referrals did not meet the NICE criteria, suggesting that the system is being used as a rapid access route to investigation. Despite this, there is no significant difference in the pickup rate of colorectal cancer in patients with or without high-risk features. Nurse-led 2WW clinics with subsequent investigation appear to be effective in both the identification and exclusion of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25244412     DOI: 10.1097/MEG.0000000000000206

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  2 in total

1.  Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing.

Authors:  Y Maeda; E Gray; J D Figueroa; P S Hall; D Weller; M G Dunlop; F V N Din
Journal:  BJS Open       Date:  2021-07-06

2.  Rapid diagnostic pathways for suspected colorectal cancer: views of primary and secondary care clinicians on challenges and their potential solutions.

Authors:  Maria Theresa Redaniel; Matthew Ridd; Richard M Martin; Fareeda Coxon; Mona Jeffreys; Julia Wade
Journal:  BMJ Open       Date:  2015-10-22       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.